Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

被引:4
|
作者
Furukawa, Daisuke [1 ,2 ,3 ]
Chijiwa, Tsuyoshi [4 ]
Matsuyama, Masahiro [3 ]
Mukai, Masaya [5 ]
Matsuo, Ei-Ichi [6 ]
Nishimura, Osamu [7 ]
Kawai, Kenji [4 ]
Suemizu, Hiroshi [4 ]
Nakagohri, Toshio [3 ]
Ozawa, Soji [3 ]
Shimada, Kazuaki [8 ]
Hiraoka, Nobuyoshi [1 ,2 ]
Nakamura, Masato [9 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol & Clin Labs, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan
[3] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[4] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan
[5] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan
[6] Shimadzu Co Ltd, Global Applicat Dev Ctr, Kyoto 6048511, Japan
[7] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[8] Natl Canc Ctr, Res Inst, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan
[9] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan
关键词
zinc finger protein 185; pancreatic ductal carcinoma; prognosis; hematogenous metastasis; subcellular location; LIVER METASTASIS; COLON-CANCER; PAXILLIN; GEMCITABINE; PROTEIN;
D O I
10.3892/ol.2017.6633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and-positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
引用
收藏
页码:3633 / 3640
页数:8
相关论文
共 50 条
  • [31] Retroviral expression screening of oncogenes in pancreatic ductal carcinoma
    Kisanuki, H
    Choi, YL
    Wada, T
    Moriuchi, R
    Fujiwara, S
    Kaneda, R
    Koinuma, K
    Ishikawa, M
    Takada, S
    Yamashita, Y
    Mano, H
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) : 2170 - 2175
  • [32] Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
    Naito, Yoshiki
    Akiba, Jun
    Kinjo, Yoshinao
    Sadashima, Eiji
    Ogata, Toshiro
    Yano, Yuta
    Tanigawa, Masakio
    Nakayama, Masamichi
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Sakai, Hisamune
    Hisaka, Toru
    Akagi, Yoshito
    Yano, Hirohisa
    ANTICANCER RESEARCH, 2022, 42 (08) : 4145 - 4151
  • [33] Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
    Yamamoto, S
    Tomita, Y
    Hoshida, Y
    Morooka, T
    Nagano, H
    Dono, K
    Umeshita, K
    Sakon, M
    Ishikawa, O
    Ohigashi, H
    Nakamori, S
    Monden, M
    Aozasa, K
    CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2846 - 2850
  • [34] MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas
    Saitou, M
    Goto, M
    Horinouchi, M
    Tamada, S
    Nagata, K
    Hamada, T
    Osako, M
    Takao, S
    Batra, SK
    Aikou, T
    Imai, K
    Yonezawa, S
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (08) : 845 - 852
  • [35] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
    R Grützmann
    J Lüttges
    B Sipos
    O Ammerpohl
    F Dobrowolski
    I Alldinger
    S Kersting
    D Ockert
    R Koch
    H Kalthoff
    H K Schackert
    H D Saeger
    G Klöppel
    C Pilarsky
    British Journal of Cancer, 2004, 90 : 1053 - 1058
  • [36] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
    Grützmann, R
    Lüttges, J
    Sipos, B
    Ammerpohl, O
    Dobrowolski, F
    Alldinger, I
    Kersting, S
    Ockert, D
    Koch, R
    Kalthoff, H
    Schackerts, HK
    Saeger, HD
    Klöppel, G
    Pilarsky, C
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 1053 - 1058
  • [37] Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma
    Khalil, Lana
    Huang, Zhonglu
    Zakka, Katerina
    Jiang, Renjian
    Penley, McKenna
    Alese, Olatunji B.
    Shaib, Walid L.
    Wu, Christina
    Behera, Madhusmita
    Reid, Michelle D.
    El-Rayes, Bassel F.
    Akce, Mehmet
    PANCREAS, 2023, 52 (01) : E75 - E84
  • [38] Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells
    Ishikawa, M
    Yoshida, K
    Yamashita, Y
    Ota, J
    Takada, S
    Kisanuki, H
    Koinuma, K
    Choi, YL
    Kaneda, R
    Iwao, T
    Tamada, K
    Sugano, K
    Mano, H
    CANCER SCIENCE, 2005, 96 (07) : 387 - 393
  • [39] Ampullary Carcinoma-prognostic and Therapeutical Contrast to Pancreatic Ductal Adenocarcinoma
    Giehl-Brown, Esther
    Weitz, Juergen
    Distler, Marius
    ZENTRALBLATT FUR CHIRURGIE, 2022, 147 (02): : 160 - 167
  • [40] Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    O'Connor, K. M.
    Li-Chang, H. H.
    Kalloger, S. E.
    Webber, D. L.
    Owen, D. A.
    Schaeffer, D. F.
    LABORATORY INVESTIGATION, 2014, 94 : 452A - 452A